// App-Quantinova.ai

TCT-151 : Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

Researchers

Presenter

  • Sungsoo Cho

Principal Investigators

  • Jung-Sun Kim

  • Duk-Woo Park

  • In-Soo Kim

  • Tae Soo Kang

  • Jung-Min Ahn

  • Pil Hyung Lee

  • Soo-Jin Kang

  • Young-Hak Kim

  • Cheol Whan Lee

  • Seong-Wook Park

  • Yong-Joon Lee

  • Seung-Jun Lee

  • Sung-Jin Hong

  • Chul-Min Ahn

  • Byeong-Keuk Kim

  • Young-Guk Ko

  • Donghoon Choi

  • Yangsoo Jang

  • Myeong-Ki Hong

  • Seung-Jung Park

Medical Centers

  • CHA Bundang Medical Center, Seongnam, Republic of KoreaCollege of

  • Severance Hospital, Seoul, Republic of Korea

  • Yonsei University Health System, Seoul, Korea

  • Dankook University Hospital, Cheonan-si, Republic of Korea

  • Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Left main disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A